Pamela E. Scott et al. JACC 2018;71:

Slides:

Advertisements

Similar presentations

This presentation reflects the views of the presenter and does not necessarily reflect the views of the American College of Cardiology Content Distributed.

Advertisements

Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Cardiac Computed Tomography.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Test in Context: High-Sensitivity C-Reactive Protein.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Non–ST-Segment Elevation Acute Coronary.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Healthy Lifestyle and Decreasing Risk of Heart Failure.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Gastrointestinal Bleeding in Patients With Atrial.

From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.

(p < for group 1 or 2 vs. group 3)

Glenn N. Levine et al. JACC 2016;68:

Table. Clinical Efficacy and Safety

EUCLID Trial design: Patients with peripheral arterial disease (PAD) were randomized to ticagrelor 90 mg twice daily (n = 6,930) vs. clopidogrel 75 mg.

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Waddah Maskoun et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:

Sigfus Gizurarson et al. JACEP 2016;2:

Dean J. Kereiakes et al. JACC 2017;70:

Thomas C. Crawford et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;j.jacep

Johannes Steiner et al. JACC 2017;70:

Muhammad Shahreyar et al. JACEP 2016;j.jacep

David J.A. Jenkins et al. JACC 2018;71:

Jonathan Afilalo et al. JACC 2017;j.jacc

John A. Bittl et al. JACC 2016;68:

Ashraf Hamdan et al. JCIN 2015;8:

Yousef Rezaei, MD American Journal of Kidney Diseases

Mintu P. Turakhia et al. JACEP 2016;2:

POINT: Will New Anti-eosinophilic Drugs Be Useful in Asthma Management

Konstantinos C. Siontis et al. JACEP 2016;2:

Mitsunori Maruyama et al. JACEP 2017;3:

Matthew Oster et al. JACC 2019;73:

Factor Xa Inhibitors in Coronary Artery Disease

Svend A. Mortensen et al. JCHF 2014;2:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Nicolaj C. Hansson et al. JACC 2016;68:

Prabhat Kumar et al. JACEP 2016;j.jacep

Vittorio Calzolari et al. JACEP 2017;3:

Toshiaki Toyota et al. JCIN 2017;10:27-37

Peter E. Carson et al. JCHF 2015;3:

Pamela E. Scott et al. JACC 2018;71:

Mintu P. Turakhia et al. JACEP 2016;2:

Björn Redfors et al. JACEP 2017;j.jacep

Seung-Yul Lee et al. JCIN 2018;j.jcin

Björn Redfors et al. JACEP 2017;j.jacep

Sebastiano Sciarretta et al. JACC 2018;71:

Giuseppe Gargiulo et al. JACC 2018;71:

CAPP2: Time to first colorectal cancer in those randomized to aspirin compared with those randomized to the aspirin placebo. CAPP2: Time to first colorectal.

Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Glenn N. Levine et al. JACC 2011;58:e44-e122

Svend A. Mortensen et al. JCHF 2014;2:

Davide Capodanno et al. JCIN 2009;2:

Associations between type of MI and incident HF

Zachary L. Steinberg et al. JACC 2017;69:

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Matias B. Yudi et al. JACC 2018;71:

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

Pamela E. Scott et al. JACC 2018;71:

Increase of physical activity over time associated with lower HF risk

Omar Abdul-Jawad Altisent et al. JCIN 2016;9:

David J.A. Jenkins et al. JACC 2018;71:

Gianluigi Savarese et al. JCHF 2016;4:

Doses of trial medication in the liraglutide groups (A) and in the placebo groups (B). Doses of trial medication in the liraglutide groups (A) and in the.

Adjusted HRs for death from any cause and death from specific causes among patients with type 1 diabetes. Adjusted HRs for death from any cause and death.

A, Raw growth data were plotted by gender and adiposity classification group at age 2 months (gray box), and mean BMI for each group is shown over time.

Presentation transcript:

Pamela E. Scott et al. JACC 2018;71:1960-1969 HRs and 95% CIs for Bleeding by Gender HRs and 95% CIs for bleeding by gender for targeted CV trials and categories. The HR and 95% confidence limits that are shown do not take into account how many comparisons were made, nor do they reflect the effect of a gender after adjustment for all other factors. Apparent homogeneity or heterogeneity among gender should not be over-interpreted. Definitions for bleeding varied across trials. The reference group for each CVD area is as follows. ACS: clopidogrel as the reference group for all 3 drugs; AF: warfarin as the reference group for all 4 drugs; and CAD: placebo as the reference group for both drugs. Abbreviations as in Figure 1. Pamela E. Scott et al. JACC 2018;71:1960-1969 ©2018 by American College of Cardiology